ESMO 2019 | Gynecological cancer: not yet ready for a chemo-free era

Mansoor Raza Mirza

Mansoor Raza Mirza, MD, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, discusses PARP and antio-angiogenic agents in platinum-sensitive disease and awaiting phase III trial results in order to move towards a chemotherapy-free era in gynecological cancer. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter